NLNK - NewLink Genetics Corporation    

Float: 21.86M

Sector: Healthcare

Industry: Biotechnology

    Had positive results from a Phase 2 clinical trial on September 7, 2017, which evaluated the combination of indoximod and Merck's Keytruda in patients with advanced melanoma. It appears to be quite effective in tough-to-treat melanoma. In 2017, roughly 87,000 new cases of invasive melanoma will be diagnosed in the U.S., and sadly, over 9,700 people will die from the disease.  

   Stifel has also upgraded NLNK to a buy from $14 Price target to $29 Price target.

   Today was NLNK's first red day after a huge 2-day run up from about $8/share to a high of $19.30/share. Now it closed at 16.64 and is at 16.35 after hours.

I am very short bias toward this stock and price action heading into tomorrow due to it being the first red day of its huge run up. Don't get in short early. Wait to short into some morning strength and then profit on the fade the rest of the day. If it can't spike in the morning before 10am then after 10am volume fades and makes it a lot harder to spike in the later part of the day.

FALC - FalconStor Software, Inc.

Float: 32.07M

Sector: Technology

Industry: Application Software

   No news came out today, but it ended finishing up 77.27% on the day closing at 0.78/share. We have resistance at 0.80/share and at around $1.00/share.

ONS - Oncobiologics, Inc.

Float: 10.85M

Sector: Healthcare

Industry: Biotechnology

   Announced strategic partnership with GMS Tenshi Holdings Pte. Limited.

   First red day short pattern on an overextended stock. SSR is on though and will be slow moving and coming up on a potential mid-candle breakout pattern soon.

 ZAIS - ZAIS Group Holdings, Inc.

Float: 12.60M

Sector: Financial

Industry: Asset Management

Just based on price action a break over 3.73 can send this to around $4/share. This has been creating a huge ascending triangle for the past 4 days after its huge gap up.

Secondary options: KURA, TEVA, MRNS